Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: A randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitumumab versus gemcitabine-cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer
- Paz-Ares, L.
- Socinski, M.A.
- Shahidi, J.
- Hozak, R.R.
- Soldatenkova, V.
- Kurek, R.
- Varella-Garcia, M.
- Thatcher, N.
- Hirsch, F.R.
ISSN: 1569-8041, 0923-7534
Año de publicación: 2016
Volumen: 27
Número: 8
Páginas: 1573-1579
Tipo: Artículo
